112 related articles for article (PubMed ID: 3971385)
1. Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.
Rasmussen BB; Pedersen BV; Thorpe SM; Hilkens J; Hilgers J; Rose C
Cancer Res; 1985 Mar; 45(3):1424-7. PubMed ID: 3971385
[TBL] [Abstract][Full Text] [Related]
2. Detection of surface antigens defined by monoclonal antibodies in primary mucinous breast carcinomas. Relation to prognostic factors and recurrence-free survival.
Rasmussen BB; Rose C; Hilkens J; Hilgers J
Virchows Arch A Pathol Anat Histopathol; 1986; 409(4):497-505. PubMed ID: 3016978
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
4. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
5. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer.
Tandon AK; Clark GM; Chamness GC; McGuire WL
Cancer Res; 1990 Jun; 50(11):3317-21. PubMed ID: 2334924
[TBL] [Abstract][Full Text] [Related]
6. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
Hendler FJ; House D
Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
[TBL] [Abstract][Full Text] [Related]
7. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components.
Ceriani RL; Blank EW; Peterson JA
Cancer Res; 1987 Jan; 47(2):532-40. PubMed ID: 3791239
[TBL] [Abstract][Full Text] [Related]
8. Expression of normal and tumor-associated antigens in human breast carcinoma.
Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
[TBL] [Abstract][Full Text] [Related]
9. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
10. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
de la Torre M; Heldin P; Bergh J
Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
[TBL] [Abstract][Full Text] [Related]
11. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
[TBL] [Abstract][Full Text] [Related]
12. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
13. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
14. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
15. Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor.
Coffer AI; Spiller GH; Lewis KM; King RJ
Cancer Res; 1985 Aug; 45(8):3694-8. PubMed ID: 4016747
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
[TBL] [Abstract][Full Text] [Related]
17. Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG).
Sauerbrei W; Royston P; Bojar H; Schmoor C; Schumacher M
Br J Cancer; 1999 Apr; 79(11-12):1752-60. PubMed ID: 10206288
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M
Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523
[TBL] [Abstract][Full Text] [Related]
20. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
